MapMembersCommitteesLegislationMoneyNominationsWatchScheduleDaily RecordSpecial RulesSubpoenasHouse EthicsForeign InfluenceAgenciesRegulationsOffice SpendingUS Code

Get a weekly summary of what Congress did, delivered every Sunday.

  • About
  • How Congress Works
  • Quiz
  • Congress Wrapped
  • Support Us
  • Roadmap
  • Health
  • Privacy Policy
  • Terms of Service
WhiteHouse.wiki•SCOTUS.wiki
Congress.wiki Alpha

This is not an official government website.

© 2026 PLEJ LC. All rights reserved.

Search⌘K
MapMembersCommitteesLegislationMoneyNominationsWatchScheduleDaily RecordSpecial RulesSubpoenasHouse EthicsForeign InfluenceAgenciesRegulationsOffice SpendingUS Code

Federal Regulations

How Congress's laws become real-world rules. Browse regulatory dockets from Regulations.gov — tracking rulemaking activity, public comment periods, and the agencies turning legislation into policy.

Dockets
7,184
Regulations.gov

Showing 30 of 7,184 dockets

Nonrulemaking
HUD

HUD-2008-0052

FR–7070–N–27 30-Day Notice of Proposed Information Collection: Section 8 Renewal Policy Guidebook; OMB Control No.: 2502–0587

12 docs12 comments
Nonrulemaking
FDA

FDA-2026-H-1889

DAB Civil Money Penalty; Inshah Enterprise LLC d/b/a Richard's Grocery Store; CLOSED 03/23/2026

1 docNo comments
Nonrulemaking
FDA

FDA-2026-H-1563

DAB Civil Money Penalty; Stay High Smoke Shop LLC, d/b/a Stay High Smoke & Vape; CLOSED 03/23/2026

1 docNo comments
Nonrulemaking
FDA

FDA-2026-H-0642

DAB Civil Money Penalty; 4S Deli Grocery Store Inc. d/b/a 4S Deli Grocery Inc.; CLOSED 03/23/2026

1 docNo comments
Nonrulemaking
FDA

FDA-2026-H-2598

DAB Civil Money Penalty; Green Paradise, Inc. d/b/a Mobil / Izzy Express #1

1 docNo comments
Nonrulemaking
FDA
Open for Comments

FDA-2026-P-2302

Requests that the FDA declare that the drug product Buspirone Tablets, 20 mg, is suitable for consideration in an Abbreviated New Drug Application (“ANDA”).

7 docsNo comments
Nonrulemaking
FDA

FDA-2025-P-5582

Requests that prior to granting full approval, the FDA take immediate administrative action requiring all Abbreviated New Drug Application (ANDA) holders of the powerful pulmonary drug nintedanib to undergo control and monitoring for N-nitrosamine Drug Substance-Related Impurities (NDSRIs) in all generic formulations

3 docsNo comments
Nonrulemaking
FAA
Open for Comments

FAA-2026-2415

AeroAg Solutions, LLC - Exemption/Rulemaking

3 docsNo comments
Nonrulemaking
FAA
Open for Comments

FAA-2026-2411

BHS Spraying LLC - Exemption/Rulemaking

3 docsNo comments
Nonrulemaking
FAA
Open for Comments

FAA-2022-0319

American Drone LLC - Exemption/Rulemaking

13 docs8 comments
Comments due Apr 2, 2024
Nonrulemaking
FAA
Open for Comments

FAA-2023-1277

Snyder’s Crop Service LLC - Exemption/Rulemaking

4 docsNo comments
Nonrulemaking
FAA
Open for Comments

FAA-2024-1245

DroneVantage LLC - Exemption/Rulemaking

5 docsNo comments
Nonrulemaking
FAA
Open for Comments

FAA-2025-0700

Jarrett Fischer - Exemption/Rulemaking

4 docsNo comments
Nonrulemaking
FAA
Open for Comments

FAA-2026-2474

Low Altitude Applicators LLC - Exemption/Rulemaking

2 docsNo comments
Nonrulemaking
FAA
Open for Comments

FAA-2026-2475

4 R Generation LLC - Exemption/Rulemaking

2 docsNo comments
Nonrulemaking
FAA
Open for Comments

FAA-2026-2524

EarthBalance Corporation - Exemption/Rulemaking

2 docsNo comments
Nonrulemaking
FAA
Open for Comments

FAA-2026-3037

WC Farm Flight Co LLC - Exemption/Rulemaking

2 docsNo comments
Nonrulemaking
FAA
Open for Comments

FAA-2026-3107

3D Drone Service, LLC - Exemption/Rulemaking

2 docsNo comments
Nonrulemaking
FAA
Open for Comments

FAA-2026-3108

EJ Pontiff Cranberry, Inc. - Exemption/Rulemaking

2 docsNo comments
Nonrulemaking
FEMA
Open for Comments

FEMA-2025-0344

Agency Information Collection Activities: Proposed Collection, Comment Request; Environmental and Historic Preservation Screening Form

1 doc7 comments
Comments due Apr 14, 2026
Nonrulemaking
FDA

FDA-2026-H-1725

DAB Civil Money Penalty; Roni Fresh Mart Inc. d/b/a Moncrief Corner Market / Smoke Shop; CLOSED 03/23/2026

1 docNo comments
Nonrulemaking
FDA
Open for Comments

FDA-2026-P-2258

Requests that the FDA declare that the proposed drug products, Gabapentin Powder for Oral Solution, 300 mg/sachet, 400 mg/sachet and 600 mg/sachet are suitable for submission as an ANDA.

7 docsNo comments
Nonrulemaking
FDA
Open for Comments

FDA-2026-P-2355

Requests that the FDA determine that the proposed Ibuprofen Tablets (500 mg and 700 mg) are suitable for submission as an Abbreviated New Drug Application (ANDA)

14 docsNo comments
Nonrulemaking
FDA

FDA-2025-H-5546

DAB Civil Money Penalty; Oster and Son, Inc. d/b/a Torrence Liquors; CLOSED 03/23/2026

1 docNo comments
Nonrulemaking
FDA

FDA-2025-P-5439

Requests that the FDA declare that an ANDA may be submitted for Methylphenidate Hydrochloride Chewable Tablets, 20 mg, a strength that differs from the currently approved RLD, METHYLIN (Methylphenidate Hydrochloride) Chewable Tablets, 2.5 mg, 5 mg and 10 mg, NDA # 021475, held by SPECGX LLC.

9 docsNo comments
Nonrulemaking
EPA

EPA-HQ-OW-2002-0046

Radon in Drinking Water: Health Risk Reduction and Cost Analysis

21 docs23 comments
Rulemaking
EPA

EPA-HQ-OW-2002-0021

Announcement of Regulatory Determinations for Priority Contaminants on the Drinking Water Contaminant Candidate List

97 docsNo comments
Rulemaking
EPA

EPA-HQ-OW-2002-0018

Underground Injection Control Program - Notice of Final Determination for Class V Wells

116 docs209 comments
Rulemaking
EPA

EPA-HQ-OW-2002-0008

National Primary Drinking Water Regulations: Long Term 1Enhanced Surface Water Treatment and Filter Backwash Rule

185 docsNo comments
Nonrulemaking
EPA

EPA-HQ-OW-2002-0001

Evaluation of Dredged Material Proposed for Discharge in Waters of the U.S. -- Testing Manual

6 docs14 comments
  • Previous
  • Page 146 of 240
  • Next